A detailed history of Aqr Capital Management LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 12,435 shares of GH stock, worth $379,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,435
Holding current value
$379,889
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.29 $277,300 - $451,266
12,435 New
12,435 $285,000
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $19,529 - $26,697
905 Added 3.49%
26,817 $725,000
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $1.67 Million - $2.58 Million
-64,567 Reduced 71.36%
25,912 $768,000
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $1.89 Million - $3.44 Million
90,479 New
90,479 $3.24 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $341,353 - $802,128
13,418 New
13,418 $364,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $2.21 Million - $2.95 Million
-22,351 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $300,769 - $453,963
-2,740 Reduced 10.92%
22,351 $2.78 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $367,145 - $517,599
-2,890 Reduced 10.33%
25,091 $3.73 Million
Q4 2020

Feb 16, 2021

SELL
$99.96 - $135.93 $1.11 Million - $1.51 Million
-11,129 Reduced 28.46%
27,981 $3.53 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $11,485 - $15,987
143 Added 0.37%
39,110 $4.35 Million
Q2 2020

Aug 17, 2020

BUY
$60.49 - $97.5 $963,424 - $1.55 Million
15,927 Added 69.13%
38,967 $3.11 Million
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $1.36 Million - $2.05 Million
23,040 New
23,040 $1.6 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.12B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.